|本期目录/Table of Contents|

[1]张凤英.冠状动脉介入治疗患者发生造影剂肾病的危险因素[J].慢性病学杂志,2013,(10):762-764.
　ZHANG Feng-ying.The risk factors of contrast-induced nephropathy in patients who had percutaneous coronary intervention[J].,2013,(10):762-764.
点击复制

冠状动脉介入治疗患者发生造影剂肾病的危险因素(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2013年10期
页码:
762-764
栏目:
论著
出版日期:
2013-10-30

文章信息/Info

Title:
The risk factors of contrast-induced nephropathy in patients who had percutaneous coronary intervention
作者:
张凤英
商丘市第一人民医院手术室,河南 商丘 476100
Author(s):
ZHANG Feng-ying
Department of Operating Room,The First People's Hospital of Shangqiu,Shangqui,Henan 476100,China Corresponding author:ZHANG Feng-ying,E-mail:zhangfengying07@163.com
关键词:
冠状动脉介入治疗;  造影剂肾病;  护理措施
Keywords:
Percutaneous Coronary Intervention(PCI);  Contrast-Induced Nephropathy(CIN);  Nursing measure
分类号:
R543
DOI:
-
摘要:
目的 总结分析冠状动脉介入(PCI)治疗患者发生造影剂肾病(CIN)的危险因素及护理预防措施。方法 选择2010年6月～2012年11月期间商丘市第一人民医院收治的350例实施PCI治疗的患者为研究对象,依据术后血清肌酐水平分为CIN组51例和非CIN组299例,回顾分析两组患者临床资料,总结CIN发生的危险因素以及护理预防措施。结果 CIN组患者糖尿病患病率35.29%、肾功能不全患病率21.57%、心功能不全患病率39.22%均明显高于非CIN组,CIN组造影剂用量(266.5±60.2)ml明显高于非CIN组用量(243.1±12.5)ml,CIN组年龄(63.5±2.1)岁明显高于非CIN组(52.5±3.5)岁,差异具有统计学意义(t=6.037 4,21.769 9,P<0.05); 回归分析结果表明肾功能不全、糖尿病、造影剂用量是影响CIN发生的危险因素(P<0.05); CIN组患者术后1年心肌梗死率5.88%、心源性猝死率11.76%、心脏事件发生率17.65%明显高于非CIN组,差异具有统计学意义(P<0.05)。结论 PCI治疗后发生CIN的相关因素主要包括肾功能不全、糖尿病等,临床要针对这些高危因素在围手术期做好预防措施,细致观察病情,精确记录尿量,给予系统化有效护理,以期改善预后。
Abstract:
Objective To summarize and analyze the risk factors of having and nursing treatment to prevent Contrast-Induced Nephropathy(CIN)in patients with Percutaneous Coronary Intervention(PCI)therapy. Methods 350 patients who had PCI were selected from June to November,2010 in our hospital.These patients were divided into two groups based on serum creatinine postoperative level; 51 cases were in group of non-CIN and the other 299 cases were in CIN group.Retrospective analysis method was used to analyze the clinical data of two groups of patients.CIN risk factors were summarized and nursing and prevention measures were adjusted. Results The diabetes prevalence rate in CIN patients was 35.29%,renal insufficiency prevalence rate was 21.57%,and cardiac insufficiency prevalence rate was 39.22%.These were obviously higher than in non-CIN group.In CIN group patients,contrast agent dosage was(266.5 ± 60.2)ml which was higher than that in CIN group(243.1 ± 12.5)ml.In CIN group,the average age(63.5 ± 2.1)was statistically significant higher than non-CIN Group(52.5 ± 3.5)(P<0.05).It showed by regression analysis that renal insufficiency,diabetes mellitus,contrast media consumption were risk factors causing CIN(P<0.05).The postoperative myocardial(1 year)infarction rate,sudden cardiac death rate,and cardiac accident rate of CIN patients were 5.88%,11.76%,and 17.65% respectively,and these were statistically significant higher than CIN group(P<0.05). Conclusions The risk factors of CIN after PCI treatment include renal insufficiency,diabetes and high age.It should be paid more attention to these factors in peri-operative preventive treatment.Details of patients' condition should be paid more attention to and urine output should be recorded more accurately.Nursing treatment should be systematic and effective which could improve the prognosis of PCI.

参考文献/References:

[1] 李勇,郭志刚,李鹏,等.冠状动脉介入治疗诱发造影剂肾病的危险因素及预后[J].广东医学,2008,29(5):824-826.
[2] 张翩,倪兆慧,王玲,等.冠状动脉介入术患者造影剂肾病的危险因素多中心调查[J].中国中西医结合肾病杂志,2010,11(3):214-218.
[3] 郑志伟,陈翠仪,康彦红,等.冠状动脉介入治疗后造影剂肾病的危险因素研究[J].岭南心血管病杂志,2012,18(1):17-19.
[4] 段巧言,侯毅.冠状动脉介入治疗术并发造影剂肾病的预防[J].白求恩军医学院学报,2011,9(1):34.
[5] Kini AS,Sarkar K,Rafael OC,et al.Serum creatinine ratio:a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function[J].Catheterization and Cardiovascular Interventions,2009,74(1):49-55.
[6] 宋静.冠状动脉介入治疗术后定时定量饮水研究[J].护理学杂志,2010,25(9):22-24.
[7] 温瑞芬.对先兆流产孕妇的心理指导[J].医学创新研究,2008,5(24):98.
[8] Chone E,Poh KK,Liang S,et al.Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine[J].Ann Acad Med Singapore,2010,39(5):374-380.
[9] 李梅,邵军.心血管介入治疗中造影剂肾病的研究进展[J].医学综述,2011,2(17):234.
[10] 高亢,赵燕,杨明,等.造影剂肾病临床相关因素分析[J].中国自然医学杂志,2007,9(4):284-287.
[11] 刘智辉,王玲,张政,等.血管造影术后急性肾损伤的临床相关危险因素探讨[J].上海医学,2009,32(3):191-194.

备注/Memo

备注/Memo:
作者简介:张凤英,本科,主管护师,主要从事临床介入护理的工作 通讯作者:张凤英,E-mail:zhangfengying07@163.com
更新日期/Last Update: 2013-10-30